Clinical trial
Drug Use Investigation of Ventavis for Pulmonary Arterial Hypertension (PAH)
NCT02825160 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use Investigation of Ventavis for Pulmonary Arterial Hypertension (PAH)
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2016
- Completion date
- September 27, 2023
- Enrollment
- 282 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.